Jinan Asia Pharma Tech Co., Ltd.
Contact:Forest Song
Phone: 13668828462
Tel: 86-531-67807744
Fax:86-531-67809944
Mail: asiapcc@gmail.com
Main product: APIs and Intermediates
Home
Product categories
Company Profile
Contacts
Home > Company Profile
Company Profile  Info marked by "" is verified
Name:Jinan Asia Pharma Tech Co., Ltd.
Category:LLC (Ltd Liability Corp)
Trade Category: Manufacturer
Registered Time:2010
Registered Capital:Above US$100 Million
Employees:11 - 50 People
Address:No.750, Shunhua Road,High&New Tech Zone,Jinan,Shandong,P.R.China
Website:http://www.china-aptc.com
Product/Service:APIs and Intermediates

Established at July 2010 in Shandong Service Center for Significant & New Drugs Creation in Jinan City, with 22 million Yuan registered capital, Jinan Asia Pharmachemical Tech Co.,Ltd. (APTC) is a professional company endeavoring in R&D, producing, selling APIs and intermediates and new drugs application. There are 26 staff working for APTC now, including 3 Doctors, 5 Masters and 16 undergraduates.
APTC has Chemical Synthesis laboratories, Chemical Analysis Division, Instrument Analysis Division. With more than 50 experiment equipments and analysis equipments, APTC can synthesize, analyze and test most products with advanced technology.
APTC also puts emphasis on the combination of production, research and study. APTC has been cooperating with many universities laboratories, like Lanzhou University, Nankai Universith, Shandong University, Dalian University of Technology, to develop new products.
APTC has a complete system for industrialization of research findings by cooperating stably with some famous Pharmaceutical factories and Chemical factories. APTC is preparing for own plant which will put into production at the end of 2013.
APTC has wide and unobstructed channels for sales by cooperating stably with some domestic and foreign pharmaceutical and trading companies, like Merck, Sanofi, Squibb.
Our tenet: optimize products quality, professionalize competent people, top the enterprise value, maximize social interest.